期刊文献+

氟伐他汀对溶血性磷脂酰胆碱致动脉平滑肌细胞增殖和凋亡相关因子表达的影响 被引量:1

Effect of fluvastatin on expression of apoptosis correlation factor and proliferation induced by lysophosphatidylcholine in human umbilical artery vascular smooth muscle cells
下载PDF
导出
摘要 目的:观察氟伐他汀对溶血性磷脂酰胆碱(LPC)诱导人脐动脉平滑肌细胞(HUASMC)增殖和凋亡作用的影响,探讨他汀类药物抗动脉粥样硬化的机制。方法:采用体外培养的HUASMC,待其生长到融合状态时用不同浓度(10-7~10-5mol/L)氟伐他汀和LPC(1、2.5、5mg/L)干预后用MTT法检测细胞增殖,Hoechst-33258染色法观察细胞凋亡,免疫组化染色方法和RT-PCR检测血管平滑肌凋亡相关因子Survivin、Fas的表达。结果:(1)MTT结果反映LPC作用24hHUASMC数量明显增多,增殖指数增大,氟伐他汀能抑制LPC促增殖的作用,使OD值降低,细胞数量明显减少;(2)免疫组化和RT-PCR结果显示:LPC对照组(5mg/L)和氟伐他汀处理组在作用早期(6~12h)Survivin因子表达明显,胞浆内可见大量棕黄色颗粒,随时间延长Survivin因子表达逐渐下降,72h时Survivin因子表达明显减弱,与LPC对照组比较差异有统计学意义(P<0.05);而LPC对照组和氟伐他汀处理组在早期(6~24h)Fas因子表达不明显,晚期(48~72h)可检测到Fas因子大量表达,胞浆内可见棕黄色颗粒,晚期处理组与LPC对照组比较差异有统计学意义(P<0.01)。结论:氟伐他汀抑制LPC对HUASMC的促增殖作用并诱导细胞发生凋亡,其凋亡作用主要与抑制Survivin因子和促进Fas因子表达有关。 To observe effects of fluvastatin and lysophosphatidylcholine (LPC) on the proliferation and apoptosis of human umbilical artery vascular smooth muscle cells (HUASMC) and provide a new evidence to statius in clinical application regarding antiatherosclerotic action. METHODS: Proliferation in cultured VSMC, derived from HUASMC and treated with different doses of fluvastatin and LPC, was analyzed by means of MTI' assay. Apoptosis of the cell was examined using dying Hoechst33258. Expression of Survivin and Fas were examined using immunocytochemistry and reverse transcription polymerase chain reaction method. RESULTS: (1) LPC (5 mg/L) could increase index of proliferation significantly. Compared with LPC group, fluvastatin could decrease proliferation significantly. (2) Immunocytochemistry and reverse transcription polymerase chain reaction method revealed that the apoptesis process was associated with inhibition of Survivin and activation of Fas. CONCLUSION: Fluvastatin inhibits proliferation of HUASMC induced by LPC. Fluvastatin can induce apoptosis of HUASMC in connection with down-regulation of Survivin and up-regulation of Fas.
出处 《中国临床药理学与治疗学》 CAS CSCD 2007年第6期649-654,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 溶血性磷脂酰胆碱 氟伐他汀 人脐动脉平滑肌细胞 SURVIVIN FAS lysophosphatidylcholine fluvastatin human umbilical artery vascular smooth muscle cells Survivin Fas
  • 相关文献

参考文献13

  • 1Campbell JH,Campbell GR.Culture techniques and their applications to studies of vascular smooth muscle[J].Clin Sci,1993;85:501-513.
  • 2徐仓宝,张亚萍,李玉华.内皮和平滑肌相互作用与动脉粥样硬化发生机制的研究进展[J].西安医科大学学报,1999,20(1):129-132. 被引量:6
  • 3Wassman S,Faul A,Hennen B,et al.Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function[J].Circ Res,2003;93:E98-E103.
  • 4Sindermann JR,Fan L,Weigel KA,et al.Differences in the effects of HMG-CoA reductase inhibitors on proliferation and viability of smooth muscle cells inculture[J].Atherosclerosis,2000;15:331-341.
  • 5Yamakawa T,Tanaka S,Yamakawa Y,et al.Lysophophatidylcholine activates extracellular signal-regulated kinases1/2 through reactive oxygen species in rat vascular smooth muscle cells[J].Arterioscler Thromb Vasc Biol,2002;22:752-758.
  • 6Ross R.The parhgenesis of atherosclerosisan update[J].N Engl J Med,1996;314:488-500.
  • 7Mulvihill ER,Jaeger J,Sengupta R,et al.Atherosclerotic plapue smooth muscle cells have a distinct phenotype[J].Arteioscler Thromb Vasc Biol,2004;24:1283-1289.
  • 8马秉亮,吴玉林.心血管疾病中血管平滑肌细胞增殖与药物开发[J].中国临床药理学与治疗学,2004,9(8):845-850. 被引量:4
  • 9Yone mitsu Y,Kaneda Y,Tanaka S,et al.Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo[J].Circ Res,1998;82:147.
  • 10Ambrosini G,Adida C,Altieri D.A novel antiapoptosis gene,Survivin,expressed in cancer and lymphoma[J].Nat Med,1997;3:917-921.

二级参考文献46

  • 1周爱儒,赵新荣,宋良文,王泰龄,李岱宗,顾健人,汤健.人动脉粥样硬化斑块p53基因突变的初步报告[J].中国动脉硬化杂志,1993,1(1):1-3. 被引量:2
  • 2杨方,赵培真,张英珊,韩晓男,王爱忠,陈忠,赵斌,梁凤玲.动脉粥样硬化高低发区年轻人冠状动脉硫酸软骨素蛋白聚糖的比较研究[J].中国动脉硬化杂志,1995,3(1):29-32. 被引量:3
  • 3[1]Padmini K, Parask S, Hanjong J, Thomas M, Lincoln. Activation of mitogen-activated protein kinase pathway by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells[J]. J Biol Chem, 1999;274(48):34301 -9
  • 4[2]Tanima G, Jeffrey C, Chen, Darren E, Casteel, Tammy M, et al. cGMP-dependent protein kinase inhibits serum-response element-dependent transcription by inhibiting Rho activation and functions[J]. J Biol Chem, 2002;277(40):37382- 93
  • 5[3]Heiko E, Von DL, Victor JD. Therapeutic potential of nitric oxide synthase gene manipulation[J]. Circulation, 2001; 103:2760 - 5
  • 6[4]Jean FA, Francis B. Alteration in endothelial estrogen receptor expression: A potential key of vasculoprotection by estrogens[J]Circ Res, 2002;91:759 - 60
  • 7[5]Tomi S, Mikkola, Thomas B, Clarkson. Estrogen replacement therapy, atherosclerosis, and vascular function[J]. Cardiovasc Res, 2002;53:605- 19
  • 8[6]Raghvendra K, Dubey, Delbert G, Gillespie, Lefteris C, Zacharia, et al. Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms [ J ]. Biochem Biophys Res Commun, 2000;278:27- 33
  • 9[7]Takuya W, Rajbabu P, Shinji K, Takashi K, Claude R, Benedict. Lysophosphatidyl choline and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation [ J]. Circulation,2001;103:1440-5
  • 10[8]Rajbabu P, Claude B. Synergy between thrombin and serotonin in inducing vascular smooth muscle cell proliferation[J]. J Lab Clin Med, 1999; 134(6) :659 - 67

共引文献8

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部